Archived Press

ProPhase Stock Quote

2017 ProPhase Labs Annual Report

ProPhase Labs to Release Fourth Quarter/Year End Results on Tuesday, March 29th

03-25-2016 12:43:35Press Release

DOYLESTOWN, PA – March 25, 2016 - ProPhase Labs (NASDAQ: PRPH) announced today that financial results for the fourth quarter, ended December 31, 2015, will be released before the market opens on Tuesday, March 29, 2016. A conference call will be held later that morning on March 29th, at 11:00am EST. ProPhase Labs Chairman and CEO, Ted Karkus, and COO/CFO Robert Cuddihy will provide a company overview including a review of activities and fourth quarter results. There will be a question and answer session following initial remarks.

Participants wishing to ask questions may access the live call by dialing (844) 301-0501 conference ID # 76794886. A replay of the conference call will be available for 90 days on the company website www.ProPhaseLabs.com.

###

About ProPhase Labs

ProPhase Labs is a diversified natural health medical science company. It is a leading marketer of the Cold-EEZE® cold remedy brand as well as other cold and flu relief products. Cold-EEZE® cold remedy zinc gluconate lozenges are clinically proven to significantly reduce the duration of the common cold. Cold-EEZE® cold remedy customers include leading national chain, regional, specialty and local retail stores. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE® cold remedy lozenges and fulfill other contract manufacturing opportunities. For more information visit us at www.ProPhaseLabs.com.